Want to see IN:INDOUS full AI Analyst Report?
INDOUS Stock Chart & Stats
₹108.00
-₹4.85(-1.77%)
At close: 4:00 PM EST
₹108.00
-₹4.85(-1.77%)
Day’s Range― - ―
52-Week Range₹75.70 - ₹158.85
Previous CloseN/A
Volume1.20K
Average Volume (3M)983.00
Market Cap
₹1.67B
Enterprise Value₹3.00K
Total Cash (Recent Filing)₹5.88M
Total Debt (Recent Filing)₹276.43M
Price to Earnings (P/E)14.5
Beta0.86
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.56
Shares Outstanding20,052,000
10 Day Avg. Volume961
30 Day Avg. Volume983
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)2.24
Price to Sales (P/S)1.87
P/FCF Ratio-13.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthThe sharp FY2026 revenue increase indicates strong demand for the company’s seed portfolio and effective commercialization through its agricultural distribution network, providing a meaningful growth base over the next several months.
Growing Equity BaseA larger equity base and expanding asset position provide greater support for production, processing, research, and distribution activities, while improving the company’s capacity to absorb operating volatility.
Integrated Seed Business ModelParticipation across seed research, production, processing, and marketing gives the business multiple operational capabilities and supports control over product development, quality, and commercialization in a structurally essential agricultural market.
Bears Say
Negative Free Cash FlowSustained negative operating and free cash flow indicates weak conversion of reported earnings into liquidity, potentially reflecting working-capital intensity or investment needs and limiting funds available for growth and debt service.
Rising DebtHigher debt increases financial risk while cash generation is weak. If negative free cash flow persists, the company may face greater refinancing needs and reduced flexibility to fund seed development, inventory, or expansion.
Weak Earnings QualityProfit did not keep pace with sales, suggesting cost pressure, pricing challenges, or other operating headwinds. Thin prior operating margins also make the recent growth less durable until margin improvement is demonstrated.
Indo US Bio-Tech Ltd. News
INDOUS FAQ
What was Indo US Bio-Tech Ltd.’s price range in the past 12 months?
Indo US Bio-Tech Ltd. lowest stock price was ₹75.70 and its highest was ₹158.85 in the past 12 months.
What is Indo US Bio-Tech Ltd.’s market cap?
Indo US Bio-Tech Ltd.’s market cap is ₹1.67B.
When is Indo US Bio-Tech Ltd.’s upcoming earnings report date?
Indo US Bio-Tech Ltd.’s upcoming earnings report date is Nov 12, 2026 which is in 78 days.
How were Indo US Bio-Tech Ltd.’s earnings last quarter?
Indo US Bio-Tech Ltd. released its earnings results on Aug 12, 2026. The company reported ₹1.515 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Indo US Bio-Tech Ltd. overvalued?
According to Wall Street analysts Indo US Bio-Tech Ltd.’s price is currently Overvalued.
Does Indo US Bio-Tech Ltd. pay dividends?
Indo US Bio-Tech Ltd. pays a N/A dividend of ₹0.25 which represents an annual dividend yield of N/A. See more information on Indo US Bio-Tech Ltd. dividends here
What is Indo US Bio-Tech Ltd.’s EPS estimate?
Indo US Bio-Tech Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Indo US Bio-Tech Ltd. have?
Indo US Bio-Tech Ltd. has 20,052,000 shares outstanding.
What happened to Indo US Bio-Tech Ltd.’s price movement after its last earnings report?
Indo US Bio-Tech Ltd. reported an EPS of ₹1.515 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.271%.
Which hedge fund is a major shareholder of Indo US Bio-Tech Ltd.?
Currently, no hedge funds are holding shares in IN:INDOUS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Indo US Bio-Tech Ltd.
Indo Us Bio-Tech Ltd. is an Indian firm specializing in the entire seed value chain, encompassing production, processing, packaging, and distribution across India. Their diverse product lineup features an extensive selection of vegetable seeds, including tomato, okra, bottle gourd, brinjal, carrot, cluster bean, bitter gourd, ridge gourd, cucumber, cabbage, radish, sponge gourd, various peppers (chili and sweet pepper), beetroot, cowpea, coriander, onion, watermelon, and muskmelon. The company also provides ornamental flower seeds, cotton seeds, and a variety of oilseeds such as castor, groundnut, sesame, mustard, and soybean. Furthermore, their offerings extend to spice seeds like cumin and psyllium (isabgul), pulse seeds including val, gram, black gram, and green gram, and cereal seeds such as wheat, maize, bajra, and pigeon pea. Beyond its domestic operations, Indo Us Bio-Tech Ltd. actively exports its agricultural products. The company was founded in 2004 and is headquartered in Ahmedabad, India.
Technical Analysis
Astec Lifesciences Limited
―
Best Agrolife Ltd.
―
India Pesticides Ltd.
―
Nath Bio-Genes (India) Ltd.
―
Indogulf Cropsciences Limited
―